Skip to content
Adam Torkildson – Lifestyle
Author:
MyOme, Inc
MyOme Launches CASRcade, a No Charge Family Cascade Genetic Testing Program for Families Affected by ADH1
October 8, 2026
MyOme and Oracle Collaborate to Advance Genomic Risk Prediction at Global Scale
September 24, 2026
MyOme Strengthens Board with Appointment of Two Healthcare Leaders
April 21, 2026
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
March 12, 2026